This study for the first time reports the prognostic (DFS, OS) values of the S100 gene family in CRC using bioinformatics tools, and our findings will underpin further studies on the mechanisms of dysregulated S100 genes in CRC, therapeutic targets, and optimization of treatment plans with improved prognosis. This evidence concerns the gene S100A1 and colorectal carcinoma.